Lv4
760 积分 2025-08-25 加入
Discovery and preclinical evaluations of TQB3616, a novel CDK4-biased inhibitor
19天前
已完结
Combining antibody-drug conjugates with immunotherapy in solid tumors: current landscape and future perspectives
19天前
已完结
Real-World Outcomes of Everolimus and Exemestane for the Treatment of Metastatic Hormone Receptor-Positive Breast Cancer in Patients Previously Treated With CDK4/6 Inhibitors
1个月前
已完结
PACE: A Randomized Phase II Study of Fulvestrant, Palbociclib, and Avelumab After Progression on Cyclin-Dependent Kinase 4/6 Inhibitor and Aromatase Inhibitor for Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor–Negative Metastatic Breast Cancer
1个月前
已完结
ABC8 Consensus: Assessment by a German Group of Experts
1个月前
已完结
Chinese expert consensus on multidisciplinary management of cancer treatment-related cutaneous adverse events (2026 edition)
1个月前
已完结
Chinese expert consensus on multidisciplinary management of cancer treatment-related cutaneous adverse events (2026 edition)
1个月前
已完结
[Chinese expert consensus on diagnosis of pleural effusion]
1个月前
已完结
Oral mucositis associated with antibody-drug conjugates in gynecologic oncology: strategies for prevention and treatment
1个月前
已完结
Comparison of the prognostic effect of pyrotinib plus trastuzumab and chemotherapy different lines therapy in HER2-positive advanced breast cancer
1个月前
已完结
蔚蓝之下，谁是海洋中的常住“居民”？
24天前
已采纳
皖公网安备34019202002308
